Clinical Trial Update: A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric Cancers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating tasquinimod in advanced/metastatic hepatocellular, ovarian, renal cell, and gastric cancers has been completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Hepatocellular Carcinoma
• Ovarian Cancer
• Renal Cell Carcinoma

Drugs mentioned

• Tasquinimod (tasquinimod)

Snippet

Sponsor: Ipsen | Conditions: Advanced or Metastatic Hepatocellular Cancer, Advanced or Metastatic Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-05-07